⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck

Official Title: An International Expanded Access Clinical Programme With ZD1839 (IRESSA) for Patients With Advanced Non-small Cell Lung Cancer(NSCLC) and Patients With Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck (H&NC)

Study ID: NCT00684385

Interventions

ZD1839

Study Description

Brief Summary: The purpose of this study is to provide ZD1839 for those patients with locally advanced and/or metastatic non-operable non-small cell lung cancer (stage III or IV) or recurrent and/or metastatic squamous cell head and neck cancer who receive the therapy on an expanded access basis due to their inability to meet eligibility criteria for on-going recruiting trials, inability to participate in other clinical trials (e.g., poor performance status, lack of geographic proximity), or because other medical interventions are not considered appropriate or acceptable.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Research Site, Berlin, , Germany

Research Site, Berlin, , Germany

Research Site, Berlin, , Germany

Research Site, Berlin, , Germany

Research Site, Essen, , Germany

Research Site, Frankfurt, , Germany

Research Site, Freiburg, , Germany

Research Site, Großhansdorf, , Germany

Research Site, Göttingen, , Germany

Research Site, Halle, , Germany

Research Site, Halle, , Germany

Research Site, Heidelberg, , Germany

Research Site, Kiel, , Germany

Research Site, Laatzen, , Germany

Research Site, Lemgo, , Germany

Research Site, Löwenstein, , Germany

Research Site, Mainz, , Germany

Research Site, München, , Germany

Research Site, Nürnberg, , Germany

Research Site, Oldenburg, , Germany

Research Site, Oldenburg, , Germany

Research Site, Stralsund, , Germany

Research Site, Stuttgart, , Germany

Research Site, Trier, , Germany

Research Site, Wiesbaden, , Germany

Research Site, Budapest, , Hungary

Research Site, Budapest, , Hungary

Research Site, Budapest, , Hungary

Research Site, Kecskemét, , Hungary

Research Site, Törökbálint, , Hungary

Research Site, Gdańsk, , Poland

Research Site, Warszawa, , Poland

Research Site, Zabrze, , Poland

Research Site, Newcastle-upon-Tyne, , United Kingdom

Contact Details

Name: Yuri Rukazenkov

Affiliation: AstraZeneca

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: